Vantage Health (VNTH) 0.2000 $VNTH
Vantage Health names Joseph C. Peters to board
M2 - Thu Sep 25, 4:37AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday that it has appointed Joseph C. Peters to its board of directors, effective immediately.
Vantage Health Announces Appointment of Joseph C. Peters, Former White House Drug Policy Office's Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors
Business Wire - Wed Sep 24, 7:30AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company. Among other things, he will be involved in exploring possible applications of the Company's technology to narcotics detection. Mr. Peters will replace departing board member Will Rees.
Vantage Health appoints Dr Steven R. Steinhubl as board chairman
M2 - Wed Sep 24, 6:07AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, on Tuesday announced that it has appointed Steven R. Steinhubl, MD, as chairman of the board. Dr Steinhubl replaces interim chairman Dr Kevin Buckman, who will remain with the company in an advisory capacity.
Vantage Health Names Dr. Steven R. Steinhubl, Director of Digital Medicine at Scripps Translational Science Institute, New Chairman of the Board
Business Wire - Tue Sep 23, 9:21AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health" or (the "Company" today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board. Dr. Steinhubl replaces interim chairman, Dr. Kevin Buckman who will remain with the company in an advisory capacity.
Tony van Bijleveld, General Manager for Patheon/DPX, and Former General Manager Europe for Alliance Boots Walgreens, Appointed to the Vantage Health Board of Directors
Business Wire - Mon Sep 22, 11:20AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company" today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc.
Dr Kevin Buckman Named Chairman and CEO of Vantage Health
Business Wire - Tue Jul 29, 2:51PM CDT
Vantage Health (the "Company" (OTCQB:VNTH) today announced the appointment of Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO as Chairman and CEO of the Company.
WEALTHMAKERS.COM Issues Report on Vantage Health
M2 - Wed Feb 26, 7:23AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Vantage Health, Inc. (OTC: VNTH). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $0.095 and the projected short squeeze price target of $2.85 per share.
BUYINS.NET Issues Vantage Health SqueezeTrigger Report
M2 - Thu Feb 13, 7:27AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Vantage Health (OTCBB: VNTH) after releasing the latest short sale data through February 11, 2014. The total aggregate number of shares shorted since March 2011 is approximately 23.35 million shares. Approximately 21.83% of daily trading volume is short selling. The SqueezeTrigger price for all VNTH shares shorted is $0.094. A short squeeze has just begun as shares of VNTH closed above the $0.094 SqueezeTrigger price.
Vantage Health names Joseph C. Peters to board
M2 - Thu Sep 25, 4:37AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday that it has appointed Joseph C. Peters to its board of directors, effective immediately.
Vantage Health Announces Appointment of Joseph C. Peters, Former White House Drug Policy Office's Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors
Business Wire - Wed Sep 24, 7:30AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company. Among other things, he will be involved in exploring possible applications of the Company's technology to narcotics detection. Mr. Peters will replace departing board member Will Rees. Vantage Health appoints Dr Steven R. Steinhubl as board chairman
M2 - Wed Sep 24, 6:07AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, on Tuesday announced that it has appointed Steven R. Steinhubl, MD, as chairman of the board. Dr Steinhubl replaces interim chairman Dr Kevin Buckman, who will remain with the company in an advisory capacity.
Vantage Health Names Dr. Steven R. Steinhubl, Director of Digital Medicine at Scripps Translational Science Institute, New Chairman of the Board
Business Wire - Tue Sep 23, 9:21AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health"
or (the "Company" today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board. Dr. Steinhubl replaces interim chairman, Dr. Kevin Buckman who will remain with the company in an advisory capacity. Tony van Bijleveld, General Manager for Patheon/DPX, and Former General Manager Europe for Alliance Boots Walgreens, Appointed to the Vantage Health Board of Directors
Business Wire - Mon Sep 22, 11:20AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc. Dr Kevin Buckman Named Chairman and CEO of Vantage Health
Business Wire - Tue Jul 29, 2:51PM CDT
Vantage Health (the "Company"
(OTCQB:VNTH) today announced the appointment of Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO as Chairman and CEO of the Company. WEALTHMAKERS.COM Issues Report on Vantage Health
M2 - Wed Feb 26, 7:23AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Vantage Health, Inc. (OTC: VNTH). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $0.095 and the projected short squeeze price target of $2.85 per share.
BUYINS.NET Issues Vantage Health SqueezeTrigger Report
M2 - Thu Feb 13, 7:27AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Vantage Health (OTCBB: VNTH) after releasing the latest short sale data through February 11, 2014. The total aggregate number of shares shorted since March 2011 is approximately 23.35 million shares. Approximately 21.83% of daily trading volume is short selling. The SqueezeTrigger price for all VNTH shares shorted is $0.094. A short squeeze has just begun as shares of VNTH closed above the $0.094 SqueezeTrigger price.
